Pregnenolone sulfate in the brain: A controversial neurosteroid

• Published in: Neurochemistry international Vol. 52; no. 4; pp. 522 - 540
• Main Authors: Schumacher, Michael, Liere, Philippe, Akwa, Yvette, Rajkowski, Krzysztof, Griffiths, William, Bodin, Karl, Sjövall, Jan, Baulieu, Etienne-Emile
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2008
• Subjects: Animals; Blood-Brain Barrier - physiology; Brain - physiology; Brain Chemistry; Dehydroepiandrosterone sulfate; GABA A receptors; Gas chromatography; Humans; Liquid chromatography; Mass spectrometry; Medicin och hälsovetenskap; Memory; Mice; Neurosteroids; NMDA receptors; Pregnenolone - antagonists & inhibitors; Pregnenolone - metabolism; Pregnenolone - physiology; Pregnenolone sulfate; Radioimmunoassay; Rats; Receptors, Neurotransmitter - drug effects; Receptors, Neurotransmitter - physiology; Sigma 1 receptors; Sulfatases - metabolism; Sulfotransferases - metabolism; DHEA; PREG; PREG-HFB; AMPA; BBB; GABA A receptor; 3β-HSD; ACh; Memory; SPE; COUMATE; PAPS; Sigma 1 receptors; STS; PNS; Radioimmunoassay; HFBA; PREGS; ent-PREGS; MS; Liquid chromatography; Gas chromatography; Dehydroepiandrosterone sulfate; Pregnenolone sulfate; GABA A receptors; mEPSCs; DU-14; EMATE; MAP-2; Mass spectrometry; GC/MS; ELISA; Neurosteroids; PPF; CNS; LTP; M; SULT; ent-allo; REM sleep; DHEAS; nat-PREGS; EPSP; OATP; RIA; NMDA receptors; LC/MS; nACh receptor; TEA; VGCC; NMDA receptor
• ISSN: 0197-0186; 1872-9754
• DOI: 10.1016/j.neuint.2007.08.022

Pregnenolone sulfate (PREGS) has been shown, either at high nanomolar or at micromolar concentrations, to increase neuronal activity by inhibiting GABAergic and by stimulating glutamatergic neurotransmission. PREGS is also a potent modulator of sigma type 1 (σ1) receptors. It has been proposed that these actions of PREGS underlie its neuropharmacological effects, and in particular its influence on memory processes. On the other hand, the PREGS-mediated increase in neuronal excitability may become dangerous under particular conditions, for example in the case of excitotoxic stress or convulsions. However, the physiopathological significance of these observations has recently been put into question by the failure to detect significant levels of PREGS within the brain and plasma of rats and mice, either by direct analytical methods based on liquid chromatography/mass spectrometry (LC/MS) or enzyme linked immunosorbent assay (ELISA) with specific antibodies against PREGS, or by indirect gas chromatography/mass spectrometry (GC/MS) analysis with improved sample workup. These recent results have not come to the attention of a large number of neurobiologists interested in steroid sulfates. However, although available direct analytical methods have failed to detect levels of PREGS above 0.1–0.3 ng/g in brain tissue, it may be premature to completely exclude the local formation of biologically active PREGS within specific and limited compartments of the nervous system. In contrast to the situation in rodents, significant levels of sulfated 3β-hydroxysteroids have been measured in human plasma and brain. Previous indirect measures of steroid sulfates by radioimmunoassays (RIA) or GC/MS had detected elevated levels of PREGS in rodent brain. The discrepancies between the results of different assay procedures have revealed the danger of indirect analysis of steroid sulfates. Indeed, PREGS must be solvolyzed/hydrolyzed prior to RIA or GC/MS analysis, and it is the released, unconjugated PREG which is then quantified. Extreme caution needs to be exercised during the preparation of samples for RIA or GC/MS analysis, because the fraction presumed to contain only steroid sulfates can be contaminated by nonpolar components from which PREG is generated by the solvolysis/hydrolysis/derivatization reactions.